Welcome to LookChem.com Sign In|Join Free

CAS

  • or

185459-60-3

Post Buying Request

185459-60-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

185459-60-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 185459-60-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,5,4,5 and 9 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 185459-60:
(8*1)+(7*8)+(6*5)+(5*4)+(4*5)+(3*9)+(2*6)+(1*0)=173
173 % 10 = 3
So 185459-60-3 is a valid CAS Registry Number.

185459-60-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1,3,5-tris(4-bromophenyl)-2,4-diazapenta-1,4-diene

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:185459-60-3 SDS

185459-60-3Upstream product

185459-60-3Relevant articles and documents

Regioselective synthesis of cis- and trans-2,4,5-triarylimidazolines and 2,4,5-triarylimidazoles from available reagents

Lozinskaya,Tsybezova,Proskurnina,Zefirov

, p. 674 - 678 (2003)

Novel data were obtained concerning the reaction of aromatic aldehydes with ammonia. A preparative method for the synthesis of new substituted 1,3,5-triaryl-2,4-diazapenta-1,4-dienes was developed. These products are the starting reactants for syntheses of cis- and trans-2,4,5-triaryl-2-imidazolines and 2,4,5-triarylimidazoles.

2,4,5-Tris(alkoxyaryl)imidazoline derivatives as potent scaffold for novel p53-MDM2 interaction inhibitors: Design, synthesis, and biological evaluation

Bazanov, Daniil R.,Pervushin, Nikolay V.,Savitskaya, Victoria Yu.,Anikina, Lada V.,Proskurnina, Marina V.,Lozinskaya, Natalia A.,Kopeina, Gelina S.

supporting information, p. 2364 - 2368 (2019/06/14)

Imidazoline-based small molecule inhibitors of p53-MDM2 interaction intended for the treatment of p53 wild-type tumors are the promising structures for design of anticancer drugs. Based on fragment approach we have investigated a key role of substituents

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 185459-60-3